Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade - Dynamique de l'information génétique : bases fondamentales et cancer Accéder directement au contenu
Article Dans Une Revue Cell Research Année : 2019

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

Takahiro Yamazaki
  • Fonction : Auteur
Maria Roberti
Miles Andrews
Gladys Ferrere
Gautier Stoll
Stefano Ugel
Shin Foong Ngiow
  • Fonction : Auteur
Armelle Prévost-Blondel
  • Fonction : Auteur
  • PersonId : 919945
Pierre-Olivier Gaudreau
  • Fonction : Auteur
Vancheswaran Gopalakrishnan
  • Fonction : Auteur
Christophe Klein
Mark Smyth
  • Fonction : Auteur
Guido Kroemer
Vincenzo Bronte
  • Fonction : Auteur

Résumé

PD-1 blockade represents a major therapeutic avenue in anticancer immunotherapy. Delineating mechanisms of secondary resistance to this strategy is increasingly important. Here, we identified the deleterious role of signaling via the type I interferon (IFN) receptor in tumor and antigen presenting cells, that induced the expression of nitric oxide synthase 2 (NOS2), associated with intratumor accumulation of regulatory T cells (Treg) and myeloid cells and acquired resistance to anti-PD-1 monoclonal antibody (mAb). Sustained IFNβ transcription was observed in resistant tumors, in turn inducing PD-L1 and NOS2 expression in both tumor and dendritic cells (DC). Whereas PD-L1 was not involved in secondary resistance to anti-PD-1 mAb, pharmacological or genetic inhibition of NOS2 maintained long-term control of tumors by PD-1 blockade, through reduction of Treg and DC activation. Resistance to immunotherapies, including anti-PD-1 mAb in melanoma patients, was also correlated with the induction of a type I IFN signature. Hence, the role of type I IFN in response to PD-1 blockade should be revisited as sustained type I IFN signaling may contribute to resistance to therapy.
Fichier principal
Vignette du fichier
s41422-019-0224-x.pdf (6.47 Mo) Télécharger le fichier
PMC6796942.html (308.97 Ko) Télécharger le fichier
Origine Publication financée par une institution
licence
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02461559 , version 1 (07-03-2024)

Licence

Identifiants

Citer

Nicolas Jacquelot, Takahiro Yamazaki, Maria Roberti, Connie Duong, Miles Andrews, et al.. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell Research, 2019, 29 (10), pp.846-861. ⟨10.1038/s41422-019-0224-x⟩. ⟨hal-02461559⟩
65 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More